Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
clinical trials
life sciences
national blog main
national top stories
3
×
new york blog main
abbvie
amgen
biotech
boston blog main
boston top stories
eli lilly
fda
national
new york top stories
acorda therapeutics
alder biopharmaceuticals
allergan
ampyra
apokyn
apomorphine
biohaven
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
cgpr
chronic migraine
dalfampridine
david rind
detroit blog main
detroit top stories
duopa
episodic migraine
eptinezumab
erenumab
europe blog main
food and drug administration
fremanezumab
galcanezumab
inbrija
indiana blog main
What
fda
new
nod
3
×
approved
class
drug
gets
medicines
migraine
treatment
acorda
adults
allergan
amgen
approval
candidates
cope
developed
disease
episodes
friday
head
help
late
looms
meant
medications
monday
pain
parkinson’s
patients
pill
preventive
rival
starts
stop
treat
ubrelvy
ubrogepant
wins
Language
unset
Current search:
nod
×
photo
×
" national top stories "
×
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines